BACKGROUND: The Asthma Control Test (ACT) has been validated in a paper and pencil version but has not been validated for use by telephone. OBJECTIVE: The purpose of this study was to provide validation data for the ACT administered by interactive telephone calls using speech recognition technology. METHODS: The ACT was administered to patients who confirmed a diagnosis of physician-diagnosed asthma, and information regarding race/ethnicity, smoking, and asthma course was also obtained during the call. Asthma emergency department visits, hospitalizations, and oral corticosteroid and beta-agonist canister dispensings were assessed for the 12 months after the date of each patient's call. Internal consistency reliability and predictive validity were assessed. RESULTS: Asthma Control Test scores (higher indicates better control) were completed by 2244 patients and were inversely related to black or Hispanic race/ethnicity and smoking. Reliability was 0.83. ACT scores were significantly related to emergency hospital care and oral corticosteroid and beta-agonist dispensings over the period of the subsequent 6 and 12 months. After adjusting for demographic characteristics, a score < or = 15 was associated significantly with an increased 12-month risk of emergency hospital care (odds ratio [OR], 2.5), oral corticosteroid dispensings (OR, 2.6) and dispensing of more than 6 beta-agonist canisters (OR, 6.8) compared with a score > or = 20. CONCLUSION: These data support the reliability and predictive validity of the ACT administered by interactive telephone calls using speech recognition technology. CLINICAL IMPLICATIONS: The ACT can be used for outreach or follow-up by means of interactive telephone calls using speech recognition technology.
BACKGROUND: The Asthma Control Test (ACT) has been validated in a paper and pencil version but has not been validated for use by telephone. OBJECTIVE: The purpose of this study was to provide validation data for the ACT administered by interactive telephone calls using speech recognition technology. METHODS: The ACT was administered to patients who confirmed a diagnosis of physician-diagnosed asthma, and information regarding race/ethnicity, smoking, and asthma course was also obtained during the call. Asthma emergency department visits, hospitalizations, and oral corticosteroid and beta-agonist canister dispensings were assessed for the 12 months after the date of each patient's call. Internal consistency reliability and predictive validity were assessed. RESULTS:Asthma Control Test scores (higher indicates better control) were completed by 2244 patients and were inversely related to black or Hispanic race/ethnicity and smoking. Reliability was 0.83. ACT scores were significantly related to emergency hospital care and oral corticosteroid and beta-agonist dispensings over the period of the subsequent 6 and 12 months. After adjusting for demographic characteristics, a score < or = 15 was associated significantly with an increased 12-month risk of emergency hospital care (odds ratio [OR], 2.5), oral corticosteroid dispensings (OR, 2.6) and dispensing of more than 6 beta-agonist canisters (OR, 6.8) compared with a score > or = 20. CONCLUSION: These data support the reliability and predictive validity of the ACT administered by interactive telephone calls using speech recognition technology. CLINICAL IMPLICATIONS: The ACT can be used for outreach or follow-up by means of interactive telephone calls using speech recognition technology.
Authors: Michelle M Cloutier; Michael Schatz; Mario Castro; Noreen Clark; H William Kelly; Rita Mangione-Smith; James Sheller; Christine Sorkness; Stuart Stoloff; Peter Gergen Journal: J Allergy Clin Immunol Date: 2012-03 Impact factor: 10.793
Authors: Gregory S Sawicki; Robert C Strunk; Brooke Schuemann; Robert Annett; Scott Weiss; Anne L Fuhlbrigge Journal: Ann Allergy Asthma Immunol Date: 2010-01 Impact factor: 6.347
Authors: Anne M Fitzpatrick; Scott E Gillespie; David T Mauger; Brenda R Phillips; Eugene R Bleecker; Elliot Israel; Deborah A Meyers; Wendy C Moore; Ronald L Sorkness; Sally E Wenzel; Leonard B Bacharier; Mario Castro; Loren C Denlinger; Serpil C Erzurum; John V Fahy; Benjamin M Gaston; Nizar N Jarjour; Allyson Larkin; Bruce D Levy; Ngoc P Ly; Victor E Ortega; Stephen P Peters; Wanda Phipatanakul; Sima Ramratnam; W Gerald Teague Journal: J Allergy Clin Immunol Date: 2019-01-08 Impact factor: 10.793
Authors: Kristin Palmsten; Michael Schatz; Priscilla H Chan; Diana L Johnson; Christina D Chambers Journal: J Allergy Clin Immunol Pract Date: 2016-01-05
Authors: Sonia Cajigal; Karen E Wells; Edward L Peterson; Brian K Ahmedani; James J Yang; Rajesh Kumar; Esteban G Burchard; L Keoki Williams Journal: J Allergy Clin Immunol Pract Date: 2016-08-17
Authors: Shelagh A Mulvaney; Yun-Xian Ho; Cather M Cala; Qingxia Chen; Hui Nian; Barron L Patterson; Kevin B Johnson Journal: J Med Internet Res Date: 2013-07-17 Impact factor: 5.428